Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
If you're over 50 and haven't saved for retirement, it's not too late. Learn essential steps to secure your financial future.
28,655 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A viral claim has sparked headlines: a bitcoin owner claims claude helped recover a lost wallet and netted $400K in B...
As oil prices rebound in 2026, investors weigh the three biggest U.S. oil majors. This report outlines buy, sell or h...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...
FIFA President Gianni Infantino defended Mexico’s readiness as violence roils the country near the World Cup. This pi...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
As Congress stalls on federal AI regulation, states are advancing targeted laws on chatbot interactions, employer use...
When a major holder exits a position, it sends a message to the market. This article breaks down what Insight Holding...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
A family emergency can attract scammers. This guide explains how impersonator lawyers operate, the real-cost risks, a...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
The stock market often rides policy signals as much as earnings. This piece digs into two decision scenarios that cou...